Third's A Charm? Merck Again Faces FDA Panel To Request Mevacor Switch To OTC
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Nonprescription Drugs and Endocrinologic and Metabolic Drugs committees to review Mevacor Rx-to-OTC switch proposal Dec. 13.